SARS-CoV-2 and the reproductive system: assessment of risk and considerations for infection control in reproductive departments.

SARS-CoV-2 and the reproductive system: assessment of risk and considerations for infection control in reproductive departments. Syst Biol Reprod Med. 2020 Sep 16;:1-4 Authors: Li G, Li W, Song B, Wu H, Tang D, Wang C, He X, Cao Y Abstract The World Health Organization has declared the outbreak of the coronavirus disease COVID-19, caused by SARS-CoV-2, a pandemic. This novel infectious disease has rapidly become a global health threat. Currently, there are limited data on the extent of reproductive system damage caused by COVID-19. We reviewed the potential risks for complications in the reproductive system caused by COVID-19 infection. In addition, based on the latest American Society for Reproductive Medicine (ASRM), and European Society of Human Reproduction and Embryology (ESHRE), recommendations regarding clinical and patient management, we provide a series of suggestions for infection control measures in reproductive medicine departments. With the gradual restoration of reproductive care services, reproductive departments in epidemic areas should actively seek to minimize COVID-19 infection of both healthcare workers and patients. PMID: 32938244 [PubMed - as supplied by publisher]
Source: Systems Biology in Reproductive Medicine - Category: Reproduction Medicine Authors: Tags: Syst Biol Reprod Med Source Type: research